|
subsections menu :
Contacts
|
Content :
2008 R&D Press releasesApril 28, 2008 U.S. Government accepts $192 million of Sanofi Pasteur H5N1 bulk vaccine antigen for pandemic stockpile
April 22, 2008 Malaria: strong partnerships aiming to benefit patients in Africa
April 15, 2008 Sanofi Pasteur invests 100 million Canadian dollars in an R&D facility in Canada to Boost Innovation in Vaccine Research for Global Health
April 10, 2008 Information available concerning the Ordinary General Meeting of May 14, 2008
March 26, 2008 NICE Recommends Acomplia® to be included in the NHS Guidance
March 21, 2008 Perioperative Eloxatin®-Based Regimen Significantly Reduced the Risk of Relapse Versus Surgery Alone in Eligible Colorectal Cancer Patients with Initially Resectable Liver Metastases
March 13, 2008 U.S. FDA Licenses DAPTACEL® Vaccine for the Fifth Consecutive Dose in the Pediatric DTaP Immunization Series
March 7, 2008 Filing of the 2007 U.S. Form 20-F and French “Document de Référence” and Annual Financial Report
March 7, 2008 Sanofi-aventis Board of Directors
March 5, 2008 New 300mg loading dose tablet for Plavix® receives positive opinion from the European Committee for Medicinal Products (CHMP)
March 3, 2008 OneWorld Health, Amyris Biotechnologies and Sanofi-aventis Announce Development Agreement for Semisynthetic Artemisinin
February 26, 2008 Sanofi Pasteur Mounts Emergency Response to Yellow Fever Epidemic in Latin America
February 19, 2008 FDA approves XYZAL® (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
February 14, 2008 Sanofi-aventis’ SoloSTAR® insulin pen for Lantus and Apidra receives the prestigious GOOD DESIGN Award
February 14, 2008 Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis
February 13, 2008 Sanofi Pasteur Files for European Approval of the First Seasonal Influenza Vaccine Delivered by Intradermal Microinjection
February 12, 2008 2007 earnings ahead of guidance - Sharp rise in proposed dividend
February 12, 2008 Sanofi-aventis enters into Antibody Agreements with Dyax for the fully human monoclonal antibody DX-2240 and "Phage Display Technology"
February 7, 2008 “Pathways of Solidarity” - a book and an exhibition
February 4, 2008 "My child matters": 25 programmes in 16 countries to fight childhood cancers
January 28, 2008 Clexane®/Lovenox® approved in Japan
January 4, 2008 Ambien CR® (zolpidem tartrate extended-release) tablets CIV improved chronic insomnia in patients with co-morbid generalized anxiety disorder
January 3, 2008 Sanofi Pasteur Enters Agreement with Crucell for Next-generation Biologicals against Rabies
|
Slots : |
